The antimicrobial peptide polyphemusin localizes to the cytoplasm of Escherichia coli following treatment

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 4, 2006, Pages 1522-1524

  Powers, Jon Paul S ^a   Martin, Morgan M ^a   Goosney, Danika L ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; BACTERIAL DNA; BIOTIN; POLYPEPTIDE ANTIBIOTIC AGENT; POLYPHEMUSIN I; TRITON X 100; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BIOTINYLATION; CIRCULAR DICHROISM; CONFOCAL MICROSCOPY; CYTOPLASM; DRUG ACCUMULATION; DRUG MECHANISM; ESCHERICHIA COLI; FLUORESCENCE MICROSCOPY; LIMULUS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEMBRANE DAMAGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CYTOPLASM; ESCHERICHIA COLI; MOLECULAR SEQUENCE DATA; OCTOXYNOL;

EID: 33645780418     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.4.1522-1524.2006     Document Type: Article

References (10)

1. Abramoff, M. D., P. J. Magelhaes, and S. J. Ram. 2004. Image processing with ImageJ. Biophotonics Int. 11:36-42.
2. Kragol, G., R. Hoffmann, M. A. Chattergoon, S. Lovas, M. Cudic, P. Bulet, B. A. Condie, K. J. Rosengren, L. J. Montaner, and L. Otvos, Jr. 2002. Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin. Eur. J. Biochem. 269:4226-4237.
3. Miyata, T., F. Tokunaga, T. Yoneya, K. Yoshikawa, S. Iwanaga, M. Niwa, T. Takao, and Y. Shimonishi. 1989. Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity. J. Biochem. (Tokyo) 106:663-668.
4. Park, C. B., H. S. Kim, and S. C. Kim. 1998. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 244:253-257.
5. Powers, J. P., A. Tan, A. Ramamoorthy, and R. E. W. Hancock. 2005. Solution structure and interaction of the antimicrobial polyphemusins with lipid membranes. Biochemistry 44:15504-15513.
6. Powers, J. P. S., A. Rozek, and R. E. W. Hancock. 2004. Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I. Biochim. Biophys. Acta 1698:239-250.
7. Wu, M., and R. E. W. Hancock. 1999. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J. Biol. Chem. 274:29-35.
8. Yonezawa, A., J. Kuwahara, N. Fujii, and Y. Sugiura. 1992. Binding of tachyplesin I to DNA revealed by footprinting analysis: significant contribution of secondary structure to DNA binding and implication for biological action. Biochemistry 31:2998-3004.
9. Zhang, L., A. Rozek, and R. E. W. Hancock. 2001. Interaction of cationic antimicrobial peptides with model membranes. J. Biol. Chem. 276:35714-35722.
10. Zhang, L., M. G. Scott, H. Yan, L. D. Mayer, and R. E. W. Hancock. 2000. Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. Biochemistry 39:14504-14514.